Developing, funding and conducting clinical trials in immune tolerance
A clinical study for highly sensitized kidney transplant candidates
ATTAIN is currently not enrolling participants
A clinical trial to learn whether a new drug treatment plan can increase the chances for a highly sensitized kidney transplant candidate to find a well-matched kidney donor.
Learn more ›
If you are 18 to 65 years old, highly sensitized to most kidney donors, and on the kidney transplant waiting list, you may be eligible.
The ATTAIN study is being conducted at University of California, San Francisco Medical Center.